Big-money moves in the US on 23/01/12 (Thu)

Insider buys: 112 trades
Insider sales: 223 trades
Congress trades: 0 trades

Notable trades of the day

No trade stood out on this day.

Trades disclosed this day

TCG Opportunity III GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$994.8K
209,000 sh
$994.8K
Filed 23/01/12
Traded 23/01/11
Column Group III10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$994.8K
209,000 sh
$994.8K
Filed 23/01/12
Traded 23/01/11
Column Group Opportunity III GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$994.8K
209,000 sh
$994.8K
Filed 23/01/12
Traded 23/01/11
Column Group Opportunity III10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$994.8K
209,000 sh
$994.8K
Filed 23/01/12
Traded 23/01/11
Column Group GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$994.8K
209,000 sh
$994.8K
Filed 23/01/12
Traded 23/01/11
TCG IV GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$994.8K
209,000 sh
$994.8K
Filed 23/01/12
Traded 23/01/11
Column Group IV-A10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$994.8K
209,000 sh
$994.8K
Filed 23/01/12
Traded 23/01/11
Column Group Iii-A10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$994.8K
209,000 sh
$994.8K
Filed 23/01/12
Traded 23/01/11
Column Group IV10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$994.8K
209,000 sh
$994.8K
Filed 23/01/12
Traded 23/01/11
Column Group IV GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$994.8K
209,000 sh
$994.8K
Filed 23/01/12
Traded 23/01/11
Tim Kutzkey10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$994.8K
209,000 sh
$994.8K
Filed 23/01/12
Traded 23/01/11
Ponoi Capital10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$994.8K
209,000 sh
$994.8K
Filed 23/01/12
Traded 23/01/11
Ponoi Capital II10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$994.8K
209,000 sh
$994.8K
Filed 23/01/12
Traded 23/01/11
Ponoi Management10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$994.8K
209,000 sh
$994.8K
Filed 23/01/12
Traded 23/01/11
Column Group II GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$994.8K
209,000 sh
$994.8K
Filed 23/01/12
Traded 23/01/11
Column Group II10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$994.8K
209,000 sh
$994.8K
Filed 23/01/12
Traded 23/01/11
Column Group Management10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$994.8K
209,000 sh
$994.8K
Filed 23/01/12
Traded 23/01/11
Peter Svennilson10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$994.8K
209,000 sh
$994.8K
Filed 23/01/12
Traded 23/01/11
Ponoi II Management10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$994.8K
209,000 sh
$994.8K
Filed 23/01/12
Traded 23/01/11
Pangaea Three-B10% Owner
BuyAlTi Global
Buy
AlTi Global
ALTI
$696K
73,187 sh
$696K
Filed 23/01/12
Traded 23/01/11
CGC Sponsor10% Owner
BuyAlTi Global
Buy
AlTi Global
ALTI
$696K
73,187 sh
$696K
Filed 23/01/12
Traded 23/01/11
TCG Opportunity III GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$484.3K
100,070 sh
$484.3K
Filed 23/01/12
Traded 23/01/10
Column Group Iii-A10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$484.3K
100,070 sh
$484.3K
Filed 23/01/12
Traded 23/01/10
Column Group Opportunity III10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$484.3K
100,070 sh
$484.3K
Filed 23/01/12
Traded 23/01/10
Column Group GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$484.3K
100,070 sh
$484.3K
Filed 23/01/12
Traded 23/01/10
Column Group Opportunity III GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$484.3K
100,070 sh
$484.3K
Filed 23/01/12
Traded 23/01/10
Column Group III10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$484.3K
100,070 sh
$484.3K
Filed 23/01/12
Traded 23/01/10
Column Group IV10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$484.3K
100,070 sh
$484.3K
Filed 23/01/12
Traded 23/01/10
Column Group IV-A10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$484.3K
100,070 sh
$484.3K
Filed 23/01/12
Traded 23/01/10
TCG IV GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$484.3K
100,070 sh
$484.3K
Filed 23/01/12
Traded 23/01/10
Column Group IV GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$484.3K
100,070 sh
$484.3K
Filed 23/01/12
Traded 23/01/10
Ponoi Management10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$484.3K
100,070 sh
$484.3K
Filed 23/01/12
Traded 23/01/10
Peter Svennilson10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$484.3K
100,070 sh
$484.3K
Filed 23/01/12
Traded 23/01/10
Tim Kutzkey10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$484.3K
100,070 sh
$484.3K
Filed 23/01/12
Traded 23/01/10
Ponoi Capital10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$484.3K
100,070 sh
$484.3K
Filed 23/01/12
Traded 23/01/10
Ponoi Capital II10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$484.3K
100,070 sh
$484.3K
Filed 23/01/12
Traded 23/01/10
Ponoi II Management10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$484.3K
100,070 sh
$484.3K
Filed 23/01/12
Traded 23/01/10
Column Group II GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$484.3K
100,070 sh
$484.3K
Filed 23/01/12
Traded 23/01/10
Column Group Management10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$484.3K
100,070 sh
$484.3K
Filed 23/01/12
Traded 23/01/10
Column Group II10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$484.3K
100,070 sh
$484.3K
Filed 23/01/12
Traded 23/01/10
Pangaea Three-B10% Owner
BuyAlTi Global
Buy
AlTi Global
ALTI
$385.6K
38,403 sh
$385.6K
Filed 23/01/12
Traded 23/01/12
CGC Sponsor10% Owner
BuyAlTi Global
Buy
AlTi Global
ALTI
$385.6K
38,403 sh
$385.6K
Filed 23/01/12
Traded 23/01/12
CGC Sponsor10% Owner
BuyAlTi Global
Buy
AlTi Global
ALTI
$365.3K
41,000 sh
$365.3K
Filed 23/01/12
Traded 23/01/10
Pangaea Three-B10% Owner
BuyAlTi Global
Buy
AlTi Global
ALTI
$365.3K
41,000 sh
$365.3K
Filed 23/01/12
Traded 23/01/10
EcoR1 Capital10% Owner
BuyZymeworks
Buy
Zymeworks
ZYME
$7M
920,000 sh
$7M
Filed 23/01/12
Traded 23/01/10
Column GroupDirector
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$994.8K
209,000 sh
$994.8K
Filed 23/01/12
Traded 23/01/11
Column GroupDirector
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$994.8K
209,000 sh
$994.8K
Filed 23/01/12
Traded 23/01/11
Column GroupDirector
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$994.8K
209,000 sh
$994.8K
Filed 23/01/12
Traded 23/01/11
David V. GoeddelDirector
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$994.8K
209,000 sh
$994.8K
Filed 23/01/12
Traded 23/01/11
Peter YuDirector
BuyAlTi Global
Buy
AlTi Global
ALTI
$696K
73,187 sh
$696K
Filed 23/01/12
Traded 23/01/11